Keyphrases
Clinical Benefit
100%
Cancer Population
100%
Fluoropyrimidine
100%
DPYD Genotyping
100%
Dihydropyrimidine Dehydrogenase
28%
Uracil
28%
Hospitalization
14%
Historical Cohort
14%
DPYD Variant
14%
Intervention Group
7%
Biobank
7%
European Medicines Agency
7%
Treatment Cycle
7%
First Dose
7%
Population Level
7%
Dehydrogenase Activity
7%
Activity Testing
7%
Systemic Treatment
7%
Initial Dose
7%
Clinical Implementation
7%
Gastrointestinal Cancer Patients
7%
Genotype-guided
7%
Dihydropyrimidine Dehydrogenase Deficiency
7%
Genotype-guided Dosing
7%
Biochemistry, Genetics and Molecular Biology
Genotyping
100%
Digital Positive Youth Development
100%
Dihydropyrimidine Dehydrogenase
38%
Uracil
30%
Wild Type
23%
Phenotype
15%